Dr Reddy’s sales growth in key markets, except India, was under pressure in Q4 FY18. Graphic: MintWhat explains the 6.3% spike in Dr Reddy’s Laboratories Ltd’s shares on Tuesday? Even then, Dr Reddy’s shares outperformed. Dr Reddy’s shares had fallen by 6% till Monday, over a week ago. Profit after tax fell by 19% but mainly due to a charge related to changes in the US tax laws.

Source: Mint May 23, 2018 03:22 UTC